MétaCan
Menu
Retour à la cohorte
Enregistrement W3158986043 · doi:10.1001/jamapsychiatry.2021.0638

Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis

2021· review· en· W3158986043 sur OpenAlexafffund
Maria Jalbrzikowski, Rebecca A. Hayes, Stephen J. Wood, Dorte Nordholm, Juan Zhou, Paolo Fusar‐Poli, Peter J. Uhlhaas, Tsutomu Takahashi, Gisela Sugranyes, Yoo Bin Kwak, Daniel H. Mathalon, Naoyuki Katagiri, Christine I. Hooker, Lukasz Smigielski, Tiziano Colibazzi, Esther Via, Jinsong Tang, Shinsuke Koike, Paul E. Rasser, Chantal Michel, И. С. Лебедева, Wenche ten Velden Hegelstad, Camilo de la Fuente‐Sandoval, James A. Waltz, Romina Mizrahi, Cheryl M. Corcoran, Franz Resch, Christian K. Tamnes, Shalaila S. Haas, Imke Lemmers-Jansen, Ingrid Agartz, Paul Allen, G. Paul Amminger, Ole A. Andreassen, Kimberley Atkinson, Peter Bachman, Inmaculada Baeza, Helen Baldwin, Cali F. Bartholomeusz, Stefan Borgwardt, Sabrina Catalano, Michael W.L. Chee, Xiaogang Chen, Kang Ik K. Cho, Rebecca Cooper, Vanessa Cropley, Montserrat Dolz, Bjørn H. Ebdrup, Adriana Fortea, Louise Birkedal Glenthøj, Birte Glenthøj, Lieuwe de Haan, Holly Hamilton, Mathew A. Harris, Kristen M. Haut, Ying He, Karsten Heekeren, Andreas Heinz, Daniela Hubl, Wu Jeong Hwang, Michael Kaess, Kiyoto Kasai, Minah Kim, Jochen Kindler, Mallory J. Klaunig, Alex Koppel, Tina Dam Kristensen, Jun Soo Kwon, Stephen M. Lawrie, Jimmy Lee, Pablo León-Ortíz, Ashleigh Lin, Rachel Loewy, Xiaoqian Ma, Patrick D. McGorry, Philip McGuire, Masafumi Mizuno, Paul Møller, Tomás Moncada-Habib, Daniel Muñoz‐Samons, Barnaby Nelson, Takahiro Nemoto, Merete Nordentoft, M. A. Оmelchenkо, Ketil Oppedal, Lijun Ouyang, Christos Pantelis, José C. Pariente, Jayachandra M. Raghava, Francisco Reyes-Madrigal, Brian J. Roach, Jan Ivar Røssberg, Wulf Rössler, Dean F. Salisbury, Daiki Sasabayashi, Ulrich Schall, Jason Schiffman, Florian Schlagenhauf, André Schmidt, Mikkel Sørensen, Michio Suzuki, Anastasia Theodoridou, A. S. Tomyshev, Jordina Tor, Tor Gunnar Værnes, Dennis Velakoulis, Gloria D. Venegoni, Sophia Vinogradov, Christina Wenneberg, Lars T. Westlye, Hidenori Yamasue, Yuan Liu, Alison R. Yung, Thérèse van Amelsvoort, Jessica A. Turner, Theo G.M. van Erp, Paul M. Thompson, Dennis Hernaus

Notice bibliographique

RevueJAMA Psychiatry · 2021
Typereview
Langueen
DomaineMedicine
ThématiqueSchizophrenia research and treatment
Établissements canadiensUniversity of TorontoDouglas CollegeMcGill University
Organismes subventionnairesJanssen PharmaceuticalsNational Center for Advancing Translational SciencesDet Sundhedsvidenskabelige Fakultet, Københavns UniversitetNational Institute of Mental HealthHelse Sør-Øst RHFNational Health and Medical Research CouncilCanadian Institutes of Health ResearchNIHR Maudsley Biomedical Research CentreXiangya Hospital, Central South UniversityDepartment of Psychiatry, Columbia UniversityNIH Clinical CenterUniversity of California, IrvineUniversity of California, San FranciscoNational Institutes of HealthNovo Nordisk FondenUniversitätsspital ZürichMedical Research CouncilZhejiang UniversityUniversity of TokyoSeoul National University HospitalMeiji Seika PharmaKarolinska InstitutetDepartment of Health and Aged Care, Australian GovernmentInstituto de Salud Carlos IIINational Natural Science Foundation of ChinaNational Research Foundation of KoreaLundbeckfondenInstitute of Psychiatry, Psychology and Neuroscience, King’s College LondonMinisterio de Economía y CompetitividadLee Kong Chian School of Medicine, Nanyang Technological UniversityUniversitetet i OsloUniversität zu LübeckConsejo Nacional de Ciencia y TecnologíaTrygFondenCentral South UniversityUniversity of TorontoGeneralitat de CatalunyaDiakonhjemmetRussian Foundation for Basic ResearchVrije Universiteit AmsterdamSwinburne University of TechnologyCollege of Medicine, Seoul National UniversityUniversität HeidelbergNanyang Technological UniversityJapan Society for the Promotion of ScienceAstellas PharmaUniversity of EdinburghEuropean CommissionEuropean Regional Development FundUniversitat de BarcelonaUniversity of RoehamptonKing's College LondonUniversitetet i StavangerUniversität ZürichSunovionNational Alliance for Research on Schizophrenia and DepressionSouth London and Maudsley NHS Foundation TrustFaculty of Health and Medical Sciences, University of Western AustraliaNational University of SingaporeNational Institute for Health and Care ResearchNational Research FoundationRush UniversitySeoul National UniversityNational Medical Research CouncilSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungU.S. Department of Veterans AffairsUniversity of PittsburghUniversiteit MaastrichtNorges ForskningsrådAustralian GovernmentH. Lundbeck A/SFundación Alicia KoplowitzGeorgia State UniversityUniversity of Maryland, Baltimore CountyBrain and Behavior Research FoundationMcGill UniversityJapan Agency for Medical Research and DevelopmentMaryland Department of Health and Mental HygieneRegion HovedstadenUniversity of BernMedical Center, University of PittsburghNew York City Department of Health and Mental HygieneSir Run Run Shaw HospitalSistema Nacional de InvestigadoresUniversität BaselWellcome TrustEisaiUniversity of Southern CaliforniaNational Science FoundationHorizon 2020 Framework ProgrammeUniversity of MinnesotaBrigham and Women's Hospital
Mots-clésPsychosisMagnetic resonance imagingPsychiatryPsychologyMedicineAssociation (psychology)Functional magnetic resonance imagingNeurosciencePsychotherapistRadiology

Résumé

récupéré en direct d'OpenAlex

Importance: The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroimaging sample of individuals at CHR to date, aims to discover robust neurobiological markers of psychosis risk. Objective: To investigate baseline structural neuroimaging differences between individuals at CHR and healthy controls as well as between participants at CHR who later developed a psychotic disorder (CHR-PS+) and those who did not (CHR-PS-). Design, Setting, and Participants: In this case-control study, baseline T1-weighted magnetic resonance imaging (MRI) data were pooled from 31 international sites participating in the ENIGMA Clinical High Risk for Psychosis Working Group. CHR status was assessed using the Comprehensive Assessment of At-Risk Mental States or Structured Interview for Prodromal Syndromes. MRI scans were processed using harmonized protocols and analyzed within a mega-analysis and meta-analysis framework from January to October 2020. Main Outcomes and Measures: Measures of regional cortical thickness (CT), surface area, and subcortical volumes were extracted from T1-weighted MRI scans. Independent variables were group (CHR group vs control group) and conversion status (CHR-PS+ group vs CHR-PS- group vs control group). Results: Of the 3169 included participants, 1428 (45.1%) were female, and the mean (SD; range) age was 21.1 (4.9; 9.5-39.9) years. This study included 1792 individuals at CHR and 1377 healthy controls. Using longitudinal clinical information, 253 in the CHR-PS+ group, 1234 in the CHR-PS- group, and 305 at CHR without follow-up data were identified. Compared with healthy controls, individuals at CHR exhibited widespread lower CT measures (mean [range] Cohen d = -0.13 [-0.17 to -0.09]), but not surface area or subcortical volume. Lower CT measures in the fusiform, superior temporal, and paracentral regions were associated with psychosis conversion (mean Cohen d = -0.22; 95% CI, -0.35 to 0.10). Among healthy controls, compared with those in the CHR-PS+ group, age showed a stronger negative association with left fusiform CT measures (F = 9.8; P < .001; q < .001) and left paracentral CT measures (F = 5.9; P = .005; q = .02). Effect sizes representing lower CT associated with psychosis conversion resembled patterns of CT differences observed in ENIGMA studies of schizophrenia (ρ = 0.35; 95% CI, 0.12 to 0.55; P = .004) and individuals with 22q11.2 microdeletion syndrome and a psychotic disorder diagnosis (ρ = 0.43; 95% CI, 0.20 to 0.61; P = .001). Conclusions and Relevance: This study provides evidence for widespread subtle, lower CT measures in individuals at CHR. The pattern of CT measure differences in those in the CHR-PS+ group was similar to those reported in other large-scale investigations of psychosis. Additionally, a subset of these regions displayed abnormal age associations. Widespread disruptions in CT coupled with abnormal age associations in those at CHR may point to disruptions in postnatal brain developmental processes.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,005
score de la tête « metaresearch » (Gemma)0,010
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Synthèse · Signal consensuel: aucune
Score de désaccord entre enseignants0,005
Score d'incertitude au seuil0,024

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0050,010
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0010,003
Bibliométrie0,0020,002
Études des sciences et des technologies0,0000,000
Communication savante0,0010,000
Science ouverte0,0010,001
Intégrité de la recherche0,0010,000
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,044
Tête enseignante GPT0,385
Écart entre enseignants0,341 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreSynthèse

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations135
Publié2021
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueJAMA PsychiatryMême sujetSchizophrenia research and treatmentTravaux en français237 207